Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Precision Oncology

Precision Oncology
2000 FOUNDED
M&A STATUS
61-70 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of clinical research services. The company provides research in the field of oncology. It provides drug development services focused on the design and execution of clinical trials on behalf of innovative life sciences companies and not-for-profit patient organizations.

Formerly Known As
ACT Oncology
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Primary Office
  • 200 Route 31 North, Suite 102
  • Flemington, NJ 08822
  • United States

+1 (908) 000-0000

Precision Oncology Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Precision Oncology‘s full profile, request access.

Request full access to PitchBook

Precision Oncology Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Medelis Private Equity-Backed Nashville, TN 00 000000000000
0000000000 Corporation Irvine, CA 00
0000 Corporation Dublin, Ireland 00000 00000 000000000 00000
000000000 Corporation Saratoga Springs, NY 00
0000000 0000000000 Private Equity-Backed Billerica, MA 00000 00.000 000000000 00.000
To view this company’s complete list of competitors, request access »

Precision Oncology Executive Team (4)

Name Title Board
Seat
Contact
Info
Patricia Devitt-Risse Founder, President & Chief Executive Officer
Gene Vodovoz Chief Financial Officer
Julia Amo Chief Operating Officer
Gerald Messerschmidt MD Chief Medical Officer